Wednesday, 21 January 2015

A remarkable coincidence

I see Reuters is reporting US pharmaceutical company Salix has hired bankers from Centreview Partners to look at strategic options. Here is a link:

http://www.reuters.com/article/2015/01/20/us-salix-sale-exclusive-idUSKBN0KT27E20150120

What a coincidence! The news comes just after I highlighted on Tip TV on Monday that FTSE 100-listed Shire had set up two separate deal teams to look at buying either US-listed NPS or Salix but ultimately went for the former.

Still, I think I mentioned on Tip TV that Flemming Ornskov, chief executive of Shire, was still keen on Salix, which makes bowel drugs, although the rest of the board are not so sure about pursuing another large takeover having just announced the £3.5 billion acquisition of NPS.  

No comments:

Post a comment